The short version of glucagon receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-25. Anything still debated is marked as such rather than presented as settled.
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Not a small molecule |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist activity |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also in aqueous buffers |
| Storage | −20 °C or below | Protect from light and moisture |
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
An antagonist is a chemical that acts within the body to reduce the physiological activity of another chemical substance (such as an opiate); especially one that opposes the action on the nervous system of a drug or a substance occurring naturally in the body by combining with and blocking its nervous receptor. There are two main types of antagonist: direct-acting Antagonist and indirect-acting Antagonists:
The Gjyshata of Gjirokastra (headquarters: tekke of Asim Bab): the regions of Gjirokastra, Saranda and Tepelena. The Gjyshata of Korça (headquarters: tekke of Turan): the regions of Korça, Devoll, Pogradec and Kolonja, including Leskovik. The Gjyshata of Kruja (headquarters: tekke of Fushë Kruj): the regions of Kruja, Kurbin, Bulqiza, Dibra, Mat, Shkodra and Durrës. The Gjyshata of Elbasan (headquarters: tekke of Baba Xhefai): the regions of Elbasan, Gramsh, Peqin, Lushnja, Kavaja, and Librazhd, including Përrenjas. The Gjyshata of Vlora (headquarters: tekke of Kusum Bab): the regions of Vlora, Mallakastra, Fier, including Patos and Roskovec. The Gjyshata of Berat (headquarters: tekke of Prisht): the regions of Berat, Skrapar and Përmet. During the 1930s, the six gjyshata of Albania set up by Sali Njazi were:
March 27: Law on labor courts; women are granted the right to vote but not to be elected. July 13: Laws relating to the [unclear reference: "lire"] salary of married women and the contribution of spouses to household expenses. July 19: Law abolishing the deportation of repeat-offending women to penal colonies. 1908
Lamb and mutton, collectively sheep meat (or sheepmeat), is meat from the domestic sheep, Ovis aries. It is generally divided into three types: lamb, from sheep in their first year; hogget, from sheep in their second; and mutton, from older sheep. The name "mutton" comes from French language mouton, sheep. Lamb is the most expensive of the three types, and in recent decades, sheep meat has increasingly only been retailed as "lamb", sometimes stretching the accepted distinctions given above. The stronger-tasting mutton is now hard to find in many areas, despite the efforts of the Mutton Renaissance Campaign in the UK. In Australia, the term prime lamb is often used to refer to lambs raised for meat. Other languages, such as French, Spanish, and Italian, make similar or even more detailed distinctions among sheep meats by age and sometimes by sex and diet—for example, lechazo in Spanish refers to meat from milk-fed (unweaned) lambs.
== Bibliography == Martin, Christopher S.; Chung, Tammy; Langenbucher, James W. (2017). "Part 1: Defining and Characterizing the Nature and Extent of Substance Use Disorders – Historical and Cultural Perspectives on Substance Use and Substance Use Disorders". In Sher, Kenneth J. (ed.). The Oxford Handbook of Substance Use and Substance Use Disorders: Volume 1. Oxford Library of Psychology. Oxford and New York: Oxford University Press. pp. 27–59. doi:10.1093/oxfordhb/9780199381678.013.001. ISBN 978-0-19-938167-8. LCCN 2016020729. Anthony, James; Barondess, David A.; Radovanovic, Mirjana; Lopez-Quintero, Catalina (2017). "Part 1: Psychiatric Comorbidity – Polydrug Use: Research Topics and Issues". In Sher, Kenneth J. (ed.). The Oxford Handbook of Substance Use and Substance Use Disorders: Volume 2. Oxford Library of Psychology. Oxford and New York: Oxford University Press. pp. 27–59. doi:10.1093/oxfordhb/9780199381708.013.006. ISBN 978-0-19-938170-8. LCCN 2016020729. Hernández-Serrano, Olga; Gras, Maria E.; Font-Mayolas, Sílvia; Sullman, Mark J. M. (2016). "Part VI: Dual and Polydrug Abuse – Chapter 83: Types of Polydrug Usage". In Preedy, Victor R. (ed.). Neuropathology of Drug Addictions and Substance Misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Cambridge, Massachusetts: Academic Press, imprint of Elsevier. pp. 839–849. doi:10.1016/B978-0-12-800634-4.00083-4. ISBN 978-0-12-800634-4.
Sources: en.wikipedia.org
Three of the entrances took the form of free-standing pavilions or small stations, including waiting rooms: one at Bastille and two on Avenue de Wagram at Étoile. These were in a style influenced by Japanese pagodas. At Étoile Guimard provided exterior doors for elevators, although the elevators were not built. Eight simpler but still elaborate structures, labeled "Édicule B" by Guimard, were installed at the termini of Line 1 as originally opened and at two other major stations. These consisted of three-sided glass-roofed structures enclosing the stairway, with a projecting canopy. A variation on this format, "Édicule A", lacked the canopy and was erected at two stations, Saint-Paul and Reuilly–Diderot. These édicule types of entrance, which have come to be called libellules because they resemble dragonflies, in some cases had decorated wall panels surfaced in reconstituted lava. The great majority of the entrances built (154) were unroofed enclosures, dubbed an entourage. A transitional form between the entourage and the édicule, railings with a roof and canopy, was used for one entrance at the Gare de Lyon metro station. At many of the entourages, the top of the steps is surmounted by a "Métropolitain" or "Métro" sign in a holder that extends between two risers in the form of sinuous stalks, traditionally compared to lily of the valley (brin de muguet), each bearing a light in the form of a red-orange globe reminiscent of an eye or a flower.
== Coordination properties == The conjugate base of DTPA has a high affinity for metal cations. Thus, the penta-anion DTPA5− is potentially an octadentate ligand assuming that each nitrogen centre and each –COO− group acts as a centre for coordination. The formation constants for its complexes are about 100 greater than those for EDTA. As a chelating agent, DTPA wraps around a metal ion by forming up to eight bonds. Its complexes can also have an extra water molecule that coordinates the metal ion. Transition metals, however, usually form less than eight coordination bonds. So, after forming a complex with a metal, DTPA still has the ability to bind to other reagents, as is shown by its derivative pendetide. For example, in its complex with copper(II), DTPA binds in a hexadentate manner utilizing the three amine centres and three of the five carboxylates. The word "DTPA" may sometimes denote DTPA5−. For explicit disambiguation, one can write H5DTPA as opposed to DTPA5−.
To the east of the garden and near the gallery of the Center Bourse is a large square basin made at the beginning of the 2nd century, about 15 m (49 ft) on each side, in well-paired stones, comprising on the whole five courses. The paved bottom was grouted with pitch to ensure watertightness. This basin of nearly 500 mᶟ was supplied with water by a pipe collecting water from a source and emerging in the north-eastern internal side of the basin. This pipeline, which was protected by Cassis stone slabs, was recognized over more than 100 m (330 ft) to the north. This basin was used to supply water to the boats. On the western internal facing, anchor points and a reserved cavity in the paved ground, attest to the existence of a wheel which must have been 3 m (9.8 ft) in diameter, used to clear the alluvium carried by the water. It is likely that another wheel was used to lift the water.
Officers / Ceremonial dress (מדי שרד madei srad) – worn by officers, or during special events/ceremonies. Dress uniform and mess dress – worn only abroad. There are several dress uniforms depending on the season and the branch. The service uniform for all ground forces personnel is olive green. The uniforms consist of a two-pocket shirt, combat trousers, sweater, jacket or blouse, and shoes or boots. The green fatigues are the same for winter and summer and heavy winter gear is issued as needed. Women's dress parallels the men's but may substitute a skirt for the trousers. Headgear included a service cap for dress and semi-dress and a field cap or "Kova raful" bush hat worn with fatigues. IDF personnel generally wear berets in lieu of the service cap and there are many beret colors issued to IDF personnel. Paratroopers are issued a maroon beret, Golani brown, Givati purple, Nahal lime green, Kfir camouflage, Combat Engineers gray. Other beret colors are: black for armored corps, turquoise for artillery personnel. For all other ground personnel, except combat units, the beret for men was green and for women, black. In combat uniforms the Orlite helmet has replaced the British Brodie helmet Mark II/Mark III, RAC Mk II modified helmet with chin web jump harness used by paratroopers and similar to the HSAT Mk II/Mk III paratrooper helmets, US M1 helmet, and French Modèle 1951 helmet – previously worn by Israeli infantry and airborne troops from the late 1940s to the mid-1970s and early 1980s.
Sources: en.wikipedia.org
Acebutolol, sold under the brand names Sectral among others, is a beta blocker for the treatment of hypertension and arrhythmias. Acebutolol is a cardioselective beta-1 blocker and has intrinsic sympathetic activity. It is commonly used in the treatment of angina. It was patented in 1967 and approved for medical use in 1973.
=== Potato Sack === The Potato Sack was an A.R.G (alternate reality game) conceived by Valve and 13 indie video game developers as a prelude to the release of Portal 2. Portal 2 had been announced by a similar game, where a patch applied to the Steam version of Portal in March 2010, provided clues heralding the official announcement. The Potato Sack game, launched on April 1, 2011, led to the reveal of "GLaDOS@home", a spoof of distributed computer challenges, to get players to cooperate on playing the independent games as to unlock Portal 2 on Steam about 10 hours before its planned release.
== Mechanism of action == Sodium glucose cotransporters (SGLTs) are proteins that occur primarily in the kidneys and play an important role in maintaining glucose balance in the blood. SGLT1 and SGLT2 are the two most known SGLTs of this family. SGLT2 is the major transport protein and promotes reabsorption from the glomerular filtration glucose back into circulation and is responsible for approximately 90% of the kidney's glucose reabsorption. SGLT2 is mainly expressed in the kidneys on the epithelial cells lining the first segment of the proximal convoluted tubule. By inhibiting SGLT2, gliflozins prevent the kidneys' reuptake of glucose from the glomerular filtrate and subsequently lower the glucose level in the blood and promote the excretion of glucose in the urine (glucosuria).
Bromelain is an enzyme extract derived from the stems of pineapples, although it exists in all parts of the fresh plant and fruit. The extract has a history of folk medicine use. As a culinary ingredient, it may be used as a meat tenderizer. The term "bromelain" may refer to either of two protease enzymes extracted from the plants of the family Bromeliaceae, or it may refer to a combination of those enzymes along with other compounds produced in an extract. Although tested in a variety of folk medicine and research models for its possible efficacy against diseases, the only approved clinical application for bromelain was issued in 2012 by the European Medicines Agency for a topical medication, called Nexobrid, used to remove dead tissue in severe skin burns. There is no other established application for bromelain as a nutraceutical or drug.
== CGMP inspections == Regulatory agencies (including the FDA in the U.S. and regulatory agencies in many European nations) are authorized to conduct unannounced inspections, though some are scheduled. FDA routine domestic inspections are usually unannounced, but must be conducted according to 704(a) of the Food, Drug and Cosmetic Act (21 USCS § 374), which requires that they are performed at a "reasonable time". Courts have held that any time the firm is open for business is a reasonable time for an inspection.
Sources: en.wikipedia.org
Retatrutide is an investigational synthetic peptide that activates three metabolic receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes. It has not been approved for clinical use.
Earlier incretin therapies engage one or two receptors. Retatrutide adds glucagon receptor activity, which may raise energy expenditure. Whether this produces larger clinical benefits is still being tested.
It has completed phase 2 trials and moved into later-stage evaluation. No regulator has granted approval. Access outside research settings is not authorized.
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.